Fig. 2
(a) bRFS, (b) DFS, (c) CSS and (d) OS in high-risk prostate cancer in the IMRT group vs the PBT group. (e) bRFS, (f) DFS, (g) CSS and (h) OS in intermediate-risk prostate cancer in the IMR vs the PBT groups.

(a) bRFS, (b) DFS, (c) CSS and (d) OS in high-risk prostate cancer in the IMRT group vs the PBT group. (e) bRFS, (f) DFS, (g) CSS and (h) OS in intermediate-risk prostate cancer in the IMR vs the PBT groups.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close